Deletion of the p110 beta isoform of phosphoinositide 3-kinase in platelets reveals its central role in Akt activation and thrombus formation in vitro and in vivo

作者：Martin Valerie; Guillermet Guibert Julie; Chicanne Gaetan; Cabou Cendrine; Jandrot Perrus Martine; Plantavid Monique; Vanhaesebroeck Bart; Payrastre Bernard^*; Gratacap Marie Pierre

来源：Blood, 2010, 115(10): 2008-2013.

DOI：10.1182/blood-2009-04-217224

During platelet activation, phosphoinositide 3-kinases (PI3Ks) produce lipid second messengers participating in the regulation of functional responses. Here, we generated a megakaryocyte-restricted p110 beta null mouse model and demonstrated a critical role of PI3K beta in platelet activation via an immunoreceptor tyrosine-based activation motif, the glycoprotein VI-Fc receptor gamma-chain complex, and its contribution in response to G-protein-coupled receptors. Interestingly, the production of phosphatidylinositol 3,4,5-trisphosphate and the activation of protein kinase B/Akt were strongly inhibited in p110 gamma null platelets stimulated either via immunoreceptor tyrosine-based activation motif or G-protein-coupled receptors. Functional studies showed an important delay in fibrin clot retraction and an almost complete inability of these platelets to adhere onto fibrinogen under flow condition, suggesting that PI3K beta is also acting downstream of IIb beta 3. In vivo studies showed that these mice have a normal bleeding time and are not protected from acute pulmonary thromboembolism but are resistant to thrombosis after FeCl(3) injury of the carotid, suggesting that PI3K beta is a potential target for antithrombotic drugs. (Blood. 2010; 115: 2008-2013)

• 出版日期2010-3-11